Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220013917 220008353 1.84 null Disease modification (D) 2014-04-27 2014-06-07 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220031700 CYCLOPHOSPHAMIDE + FLUDARABINE
220013918 220008353 1.69 87.5 Curative (C) null 2014-04-29 CYCLOPHOSPHAMIDE + FLUDARABINE 2 N 220031700 CYCLOPHOSPHAMIDE + FLUDARABINE
220013919 220008353 1.64 72 Curative (C) 2018-02-16 2018-02-18 FLAG 2 N 220031700 FLAG
220013920 220008353 1.72 54 Curative (C) 2016-09-09 2016-09-09 Triple Intrathecal N N 220031700 TRIPLE INTRATHECAL
220013921 220008355 1.68 74.5 Curative (C) 2013-07-28 2013-07-28 Cyclophosphamide+Fludara+TBI Allo N N 220031722 CYCLOPHOSPHAMIDE + FLUDARABINE
220013922 220014535 1.68 66.2 Palliative (P) 2014-06-08 2014-10-12 Cyclophosphamide+Fludara+TBI Allo 2 N 220031724 CYCLOPHOSPHAMIDE + FLUDARABINE
220013923 220014535 1.73 77.4 Curative (C) null 2015-05-24 ATG + Busulfan + Fludarabine N N 220031724 ATG + BUSULFAN + FLUDARABINE
220013924 220008356 1.79 80 Curative (C) 2016-10-16 2016-10-22 Triple Intrathecal N N 220031734 TRIPLE INTRATHECAL
220013925 220008358 null 71.45 Disease modification (D) 2013-08-12 2013-08-12 Cyclophosphamide TBI Allograft null null 220031735 CYCLOPHOSPHAMIDE
220013926 220008360 null 127 Curative (C) 2013-05-29 2013-05-29 FLAG N null 220031736 FLAG
220013927 220008362 1.86 89.4 null 2013-04-01 2013-04-01 Cyclophosphamide oral Y N 220031736 CYCLOPHOSPHAMIDE
220013928 220008362 1.66 63.2 Curative (C) 2013-04-19 2013-04-19 Triple Intrathecal N N 220031736 TRIPLE INTRATHECAL
220013930 220008365 null 67 Curative (C) 2015-02-01 2015-02-01 Cyclophosphamide+Fludara+TBI Allo N N 220031748 CYCLOPHOSPHAMIDE + FLUDARABINE
220013931 220008366 1.7 71.8 Curative (C) 2013-10-18 2013-11-22 Triple / Double Intrathecal Therapy 2 N 220031749 TRIPLE INTRATHECAL
220013932 220014541 1.75 0 Curative (C) 2017-07-07 2017-07-13 FLAG N N 220031749 FLAG
220013933 220020947 1.67 69.4 Curative (C) 2018-11-06 2018-11-06 BOSUTINIB Y N 220031756 BOSUTINIB
220013934 220008368 1.96 88.9 Curative (C) 2016-03-25 2016-04-01 Methotrexate intrathecal N N 220031759 METHOTREXATE INTRATHECAL
220013935 220008369 1.65 13.9 Curative (C) 2014-01-16 2014-01-16 AML Int Guide ADE 8+3+5 (2) N N 220031774 ADE
220013936 220014542 1.77 95.6 null 2014-03-15 2014-05-17 BOSUTINIB null null 220031774 BOSUTINIB
220013937 220008371 1.8 7.1 Curative (C) 2018-01-01 2018-02-09 Cyclophosphamide+Fludara+TBI Allo N N 220031784 CYCLOPHOSPHAMIDE + FLUDARABINE
220013938 220008372 1.71 50.4 Curative (C) 2014-10-07 2014-10-07 FLAG N N 220031790 FLAG
220013939 220008373 0 6.6 Curative (C) null 2013-04-06 AML Int Guide ADE 8+3+5 (2) N N 220031792 ADE
220013940 220008376 null 6.5 Adjuvant (A) 2016-05-02 2016-05-12 Idarubicin+Tretinoin Spanish Crse2 N null 220031796 IDARUBICIN + TRETINOIN
220013941 220008377 null 89 null null 2018-02-12 ATG + Busulfan + Fludarabine null N 220031796 ATG + BUSULFAN + FLUDARABINE
220013942 220008380 null 80 Curative (C) 2013-12-08 2013-12-08 Idarubicin+Tretinoin Spanish Crse1 2 N 220031799 IDARUBICIN + TRETINOIN
220013943 220008382 null 83.3 Curative (C) null 2016-09-29 BOSUTINIB Y null 220031811 BOSUTINIB
220013944 220008382 1.51 58.7 Curative (C) 2017-01-12 2017-01-16 AML Int Guide ADE 8+3+5 (2) N N 220031811 ADE
220013945 220008387 1.55 54.7 Curative (C) 2018-01-11 2018-09-20 BOSUTINIB N N 220031813 BOSUTINIB
220013950 220014548 1.58 43.4 Not known (9) 2013-12-26 2013-12-26 Idarubicin+Tretinoin Spanish Crse4 N N 220031821 IDARUBICIN + TRETINOIN
220013951 220008394 1.73 68.8 Disease modification (D) 2014-05-11 2014-05-18 BOSUTINIB N N 220031822 BOSUTINIB
220013952 220008394 1.61 61.2 Palliative (P) 2017-10-22 2017-11-21 CYCLOPHOSPHAMIDE null N 220031822 CYCLOPHOSPHAMIDE
220013953 220008395 1.49 46 Palliative (P) 2013-11-08 2013-12-24 RUXOLITINIB 02 N 220031843 RUXOLITINIB
220013954 220008395 null 20 null 2015-04-27 2015-06-17 Triple / Double Intrathecal Therapy null N 220031843 TRIPLE INTRATHECAL
220013955 220008395 1.98 69.9 Palliative (P) 2016-04-17 2016-04-22 BOSUTINIB N N 220031843 BOSUTINIB
220013956 220008396 null 98.75 Disease modification (D) 2017-12-07 2017-12-07 RUXOLITINIB N N 220031869 RUXOLITINIB
220013957 220014551 0 93 Palliative (P) 2015-10-15 2015-10-18 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220031869 CYCLOPHOSPHAMIDE + FLUDARABINE
220013958 220008398 1.74 155 Palliative (P) 2015-02-14 2015-02-14 CYCLOPHOSPHAMIDE + FLUDARABINE 2 N 220031877 CYCLOPHOSPHAMIDE + FLUDARABINE
220013959 220008399 1.84 17.5 Adjuvant (A) 2017-06-20 2017-06-21 FLAG N N 220031880 FLAG
220013960 220014553 1.6 0 null 2014-05-07 2014-06-06 AML Int Guide ADE 8+3+5 (2) N N 220031880 ADE
220013961 220008401 1.56 83.8 Palliative (P) 2016-10-05 2017-07-23 BOSUTINIB N N 220031887 BOSUTINIB
220013962 220008402 null 93 null 2015-09-12 2015-09-12 BOSUTINIB 02 N 220031890 BOSUTINIB
220013963 220014554 1.75 78.4 Disease modification (D) 2017-07-13 2017-07-13 Idarubicin+Tretinoin Spanish Crse2 N null 220031890 IDARUBICIN + TRETINOIN
220013964 220008403 0 68.1 Disease modification (D) 2015-06-09 2015-06-09 RUXOLITINIB N N 220031895 RUXOLITINIB
220013965 220008405 1.63 41.9 Disease modification (D) 2015-09-20 2016-09-06 AML Int Guide ADE 8+3+5 (2) N N 220031907 ADE
220013966 220014557 0 97 null 2016-07-14 2016-07-17 Idarubicin+Tretinoin Spanish Crse4 N null 220031911 IDARUBICIN + TRETINOIN
220013967 220017955 null 60 Disease modification (D) 2016-02-12 2016-02-12 ATG + Busulfan + Fludarabine 99 N 220031916 ATG + BUSULFAN + FLUDARABINE
220013968 220017955 1.62 94.6 Adjuvant (A) 2014-07-27 2014-07-27 Methotrexate intrathecal 2 N 220031916 METHOTREXATE INTRATHECAL
220013969 220008407 1.68 60.3 Curative (C) 2012-12-21 2013-10-10 CYCLOPHOSPHAMIDE 02 Y 220031919 CYCLOPHOSPHAMIDE
220013970 220008411 0 null Disease modification (D) 2016-12-26 2017-02-09 BOSUTINIB N N 220031932 BOSUTINIB
220013971 220008412 1.72 88.3 Curative (C) 2016-03-27 2016-04-02 Methotrexate intrathecal N N 220031935 METHOTREXATE INTRATHECAL